Transthyretin-type Cardiac Amyloidosis
1 clinical trials · Condition
◉ Watch Transthyretin-type Cardiac Amyloidosis
| Record | Firm | Date |
|---|---|---|
| Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers (NCT07306949) | Alexion Pharmaceuticals, Inc. | 2025-10-01 |
Track Transthyretin-type Cardiac Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.